Monument Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $421K | Buy |
841
+80
| +11% | +$38.4K | 0.08% | 182 |
|
|
2026
Q1 | $374K | Buy |
761
+3
| +0.4% | +$1.63K | 0.09% | 156 |
|
|
2025
Q4 | $439K | Hold |
758
| – | – | 0.11% | 140 |
|
|
2025
Q3 | $367K | Sell |
758
-35
| -4% | -$16.3K | 0.09% | 160 |
|
|
2025
Q2 | $321K | Sell |
793
-58
| -7% | -$24.3K | 0.08% | 161 |
|
|
2025
Q1 | $423K | Hold |
851
| – | – | 0.13% | 128 |
|
|
2024
Q4 | $443K | Sell |
851
-14
| -2% | -$7.7K | 0.12% | 125 |
|
|
2024
Q3 | $535K | Sell |
865
-2
| -0.2% | -$1.18K | 0.15% | 108 |
|
|
2024
Q2 | $479K | Buy |
867
+14
| +2% | +$8.02K | 0.14% | 108 |
|
|
2024
Q1 | $496K | Hold |
853
| – | – | 0.14% | 119 |
|
|
2023
Q4 | $453K | Buy |
853
+50
| +6% | +$24.2K | 0.15% | 122 |
|
|
2023
Q3 | $406K | Sell |
803
-5
| -0.6% | -$2.66K | 0.14% | 117 |
|
|
2023
Q2 | $421K | Sell |
808
-5
| -0.6% | -$2.7K | 0.13% | 116 |
|
|
2023
Q1 | $468K | Buy |
813
+3
| +0.4% | +$1.69K | 0.16% | 101 |
|
|
2022
Q4 | $446K | Sell |
810
-82
| -9% | -$43.5K | 0.15% | 104 |
|
|
2022
Q3 | $452K | Sell |
892
-269
| -23% | -$151K | 0.17% | 102 |
|
|
2022
Q2 | $631K | Sell |
1,161
-135
| -10% | -$74.3K | 0.24% | 88 |
|
|
2022
Q1 | $765K | Sell |
1,296
-4,585
| -78% | -$2.63M | 0.25% | 82 |
|
|
2021
Q4 | $3.92M | Sell |
5,881
-340
| -5% | -$212K | 1.22% | 15 |
|
|
2021
Q3 | $3.55M | Sell |
6,221
-212
| -3% | -$116K | 1.21% | 14 |
|
|
2021
Q2 | $3.25M | Sell |
6,433
-150
| -2% | -$70.8K | 1.12% | 21 |
|
|
2021
Q1 | $3M | Sell |
6,583
-663
| -9% | -$316K | 1.2% | 21 |
|
|
2020
Q4 | $3.38M | Sell |
7,246
-107
| -1% | -$50.2K | 1.56% | 13 |
|
|
2020
Q3 | $3.25M | Sell |
7,353
-606
| -8% | -$250K | 1.71% | 9 |
|
|
2020
Q2 | $2.88M | Sell |
7,959
-838
| -10% | -$281K | 1.7% | 9 |
|
|
2020
Q1 | $2.5M | Sell |
8,797
-159
| -2% | -$50.1K | 1.79% | 13 |
|
|
2019
Q4 | $2.91M | Sell |
8,956
-239
| -3% | -$72.5K | 1.48% | 17 |
|
|
2019
Q3 | $2.68M | Sell |
9,195
-39
| -0.4% | -$11.2K | 1.45% | 22 |
|
|
2019
Q2 | $2.77M | Sell |
9,234
-758
| -8% | -$209K | 1.49% | 15 |
|
|
2019
Q1 | $2.73M | Sell |
9,992
-724
| -7% | -$180K | 1.56% | 15 |
|
|
2018
Q4 | $2.4M | Sell |
10,716
-3
| -0% | -$704 | 1.5% | 18 |
|
|
2018
Q3 | $2.62M | Buy |
10,719
+914
| +9% | +$210K | 1.47% | 16 |
|
|
2018
Q2 | $2.03M | Sell |
9,805
-1,073
| -10% | -$228K | 1.41% | 23 |
|
|
2018
Q1 | $2.21M | Buy |
10,878
+535
| +5% | +$112K | 1.51% | 23 |
|
|
2017
Q4 | $1.96M | Buy |
+10,343
| New | +$1.98M | 1.38% | 33 |
|
Other funds holding TMO
RG
ECSS
LT
Monument Capital Management's TMO Position: Q2 2026 in Review
Monument Capital Management increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $38.4K and bringing the position to 841 shares worth $421K. The position accounts for 0.08% of the portfolio, ranked #182.
Monument Capital Management first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.92M in Q4 2021. 1,161 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Monument Capital Management held 841 shares of Thermo Fisher Scientific worth $421K as of Q2 2026.
- Monument Capital Management bought 80 Thermo Fisher Scientific shares in Q2 2026, an estimated $38.4K.
- Thermo Fisher Scientific made up 0.08% of Monument Capital Management's portfolio in Q2 2026, its #182 holding.
- Monument Capital Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Monument Capital Management's Thermo Fisher Scientific position peaked at $3.92M in Q4 2021.
- 1,161 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.